Strides Pharma Science’s step down subsidiary Strides Pharma Canada Inc., Canada has entered into an arrangement to acquire 80% stake in Pharmapar Inc., a Canada based specialised generics front end company.
Foray in Canada which is a new market for the company and one of top 10 global pharmaceutical markets. As per IQVIA, the market is estimated at $21 billion with a significant share of generics through retail pharmacies. The company to fast track growth in the region through rapid portfolio expansion driven by its fungible portfolio built in the markets of US, Europe and Australia.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
